Philip Morris International Acquires Fertin Pharma from EQT Private Equity

Philip Morris International Acquires Vectura Group plc

July 9, 2021

Pharmaceuticals

Philip Morris International (PMI) agreed to acquire UK-based inhaled drug-delivery specialist Vectura Group plc in an all-cash recommended offer valuing Vectura at GBP 852 million (150 pence per share). The acquisition is intended to accelerate PMI's "Beyond Nicotine" strategy by adding inhaled-therapeutics R&D, device/formulation capabilities and a pipeline of inhaled and oral product opportunities.

Philip Morris Holland (PMHH) Acquires Majority Stake in Swedish Match

November 10, 2022

Consumer Products

Philip Morris Holland Holdings B.V. (an affiliate of Philip Morris International) declared its public offer for Swedish Match unconditional after receiving tenders representing ~82.6% of the share capital and subsequently purchased additional shares to reach ~85.9%. The offer priced shares at SEK 116 (reduced to SEK 115.07 for tenders in the extended period due to a dividend), with PMHH aiming to exceed 90% ownership to delist Swedish Match and integrate its oral nicotine portfolio with PMI’s IQOS business.

Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Pharmaceuticals

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

Fulgent Genetics Acquires Fulgent Pharma

November 7, 2022

Biotechnology

Fulgent Genetics completed the acquisition of Fulgent Pharma Holdings for approximately $100 million in a combination of cash and Fulgent common stock. The deal integrates Fulgent Pharma’s nanoencapsulation drug-delivery platform and clinical-stage oncology pipeline with Fulgent Genetics’ diagnostics capabilities to create a vertically integrated precision-medicine offering focused on cancer.

MidOcean Partners Acquires QualiTech

June 7, 2023

Food & Beverage

MidOcean Partners, a New York-based private equity firm, has acquired QualiTech, a family-owned manufacturer of food ingredients, animal nutrition and plant nutrition products, from the Ploen family. The transaction will provide capital to expand QualiTech’s capabilities, capacity and product innovation as part of MidOcean’s food value chain investment strategy; terms were not disclosed.

EQT Private Equity and Goldman Sachs Asset Management Acquire Parexel from Pamplona Capital Management

July 2, 2021

Healthcare Services

EQT Private Equity (EQT IX) and Goldman Sachs Asset Management's Private Equity business have agreed to acquire Parexel from Pamplona Capital Management for an enterprise value of USD 8.5 billion. Parexel, a global clinical research organization co-headquartered in Durham, North Carolina and Newton, Massachusetts, employs more than 17,000 people and provides outsourced clinical development, regulatory, market access and consulting services to the pharma and biotech industry.